Lotus Pharmaceutical Co., Ltd. Warrant logo

Lotus Pharmaceutical Co., Ltd. Warrant (057976)

Market Closed
7 Aug, 05:30 AM
TWSE TWSE
NT$
5. 60
+1.1
+24.4444%
NT$
- Market Cap
- P/E Ratio
- Div Yield
19,000 Volume
- Eps
NT$ 4.5
Previous Close
Add Transaction
Day Range
5.6 5.6
Year Range
0.45 6.5
Want to track 057976 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

057976 closed Friday higher at NT$5.6, an increase of 24.4444% from Thursday's close, completing a monthly increase of 29.6296% or NT$1.28. Over the past 12 months, 057976 stock gained 591.358%.
057976 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

057976 Chart

Lotus Pharmaceutical Co., Ltd. Warrant (057976) FAQ

What is the stock price today?

The current price is NT$5.60.

On which exchange is it traded?

Lotus Pharmaceutical Co., Ltd. Warrant is listed on TWSE.

What is its stock symbol?

The ticker symbol is 057976.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Lotus Pharmaceutical Co., Ltd. Warrant ever had a stock split?

No, there has never been a stock split.

Lotus Pharmaceutical Co., Ltd. Warrant Profile

Pharmaceuticals Industry
Healthcare Sector
- CEO
TWSE Exchange
- ISIN
Taiwan Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Lotus Pharmaceutical Co., Ltd. is a prominent entity within the pharmaceutical industry, recognized for its commitment to the development, manufacture, and distribution of high-quality generic medications and specialty drugs across various therapeutic areas. The company utilizes innovative practices to enhance its product offerings and maintain a competitive edge in the healthcare market. One of the financial instruments offered by Lotus Pharmaceutical is its warrant, a derivative security that allows holders the right, but not the obligation, to purchase shares of the company at a predetermined price within a specified timeframe. This financial tool serves multiple purposes: it aids in capital raising and contributes to strategic financial management while providing investors with the chance to gain leveraged exposure to the company’s equity without the immediate capital outlay typically required for stock purchases. By offering this warrant, Lotus Pharmaceutical not only enhances its share liquidity but also attracts a broader range of investors keen on its strategic developments in the healthcare sector, particularly in healthcare, biotechnology, and pharmaceuticals.

Products and Services

  • Generic Medications

    Lotus Pharmaceutical specializes in the formulation and production of generic drugs that serve as cost-effective alternatives to brand-name medications. These medications are designed to meet the same quality and efficacy standards as their branded counterparts, providing patients and healthcare providers with affordable treatment options across various health conditions.

  • Specialty Drugs

    The company also focuses on developing specialty drugs that target complex and chronic conditions. These medications often require unique handling, monitoring, and distribution processes, and Lotus Pharmaceutical is dedicated to ensuring that these products meet the highest standards of safety and effectiveness for patients needing advanced therapies.

  • Research and Development

    Investment in research and development is a cornerstone of Lotus Pharmaceutical's operational strategy. The company is committed to advancing healthcare solutions by innovating new drug formulations and leveraging cutting-edge technology to improve existing products. Their R&D initiatives aim to discover new therapeutic applications and create value-added products for patients.

  • Manufacturing Capabilities

    Lotus Pharmaceutical boasts state-of-the-art manufacturing facilities that adhere to stringent regulatory standards. Their capabilities allow for scalable production processes that ensure consistent quality and supply of both generic and specialty products. The company is equipped to respond to market demands efficiently while maintaining high production standards.

  • Market Expansion Strategies

    The company actively seeks to expand its market presence through strategic partnerships, collaborations, and entry into new geographical markets. By leveraging its robust portfolio of products and innovative practices, Lotus Pharmaceutical aims for sustainable growth and increased access to its medications for healthcare providers and patients globally.

Contact Information

Address: -
Phone: -